Rosen, MD, and Julie Ingelfinger, MD, from Tufts University School of Medicine and the Maine Medical Center Institute for Research (MaineHealth): #Endocrinology To view or add a comment, sign in Extraordinary article by NEJM Group The Dual Burden of Innovation: Clinical Excellence and Medicolegal Defense As both a clinician and an attorney at law, my stance on GLP-1 RAs is uncompromising
The clinical question is always "is the deficit one of desire?" and when the answer is yes, PT-141 has a mechanistically coherent rationale
Start low, increase gradually, stay consistent with weekly injections, and work closely with your provider to optimize results while managing side effects
Mickal Hiligsmann is universitair hoofddocent Gezondheidseconomie en Gezondheidstechnologiebeoordeling bij het Care and Public Health Research Institute (CAPHRI), FHML, en is hoofdredacteur bij het wetenschappelijke tijdschrift Expert Review of Pharmacoeconomics & Outcomes Research
More such battles are sure to follow, as health systems, many themselves strapped financially, seek higher payments from an insurer that is struggling to operate in the black
.png)
